9 February 2018 - An anti-HIV drug has been officially recommended to be added to the Pharmaceutical Benefits Scheme.
The cost of an expensive anti-HIV drug is set to drop below $500 a year after it was approved for addition to the Pharmaceutical Benefits Scheme.
PrEP is a once-daily pill used to prevent HIV transmission particularly among gay and bisexual men, and its cost will drop from $5000 a year.